These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 3102998

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Recommendations for blood studies and clinical monitoring in early detection of valproate-associated liver failure. Results of a consensus conferences 9 May - 11 May 1997 in Berlin].
    König SA, Elger CE, Vassella F, Schmidt D, Bergmann A, Boenigk HE, Despland PA, Genton P, Krämer G, Löscher W, Mayer T, Nau H, Schneble H, Siemes H, Stefan H, Wolf P.
    Nervenarzt; 1998 Oct; 69(10):835-40. PubMed ID: 9834471
    [Abstract] [Full Text] [Related]

  • 24. Hepatotoxicity and valproate therapy.
    Betrosian A, Frantzeskaki F.
    Intern Med J; 2006 Nov; 36(11):752-4. PubMed ID: 17040368
    [No Abstract] [Full Text] [Related]

  • 25. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G, Epifanio G, Auricchio G, Federico RR, Resicato G, Pascotto A.
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [Abstract] [Full Text] [Related]

  • 26. Valproate-associated pancreatitis.
    Asconapé JJ, Penry JK, Dreifuss FE, Riela A, Mirza W.
    Epilepsia; 1993 Jul; 34(1):177-83. PubMed ID: 8422855
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Abnormal alterations in the metabolic patterns of patients on valproate therapy.
    Kreher U, Darius J, Wien F.
    J Pharm Pharmacol; 2002 Jul; 54(7):989-95. PubMed ID: 12162719
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Fatal hepatic necrosis during treatment with sodium valproate].
    Miguil M, Chlihi A, Mjahed K, Sarf I, Moutawakkil S, Benaguida M.
    Cah Anesthesiol; 1995 Jul; 43(3):325-6. PubMed ID: 7583902
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents.
    Rahman A, Mican LM, Fischer C, Campbell AH.
    Ann Pharmacother; 2009 May; 43(5):822-30. PubMed ID: 19401471
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Valproate hepatotoxicity: a review and report of two instances in adults.
    Dickinson RG, Bassett ML, Searle J, Tyrer JH, Eadie MJ.
    Clin Exp Neurol; 1985 May; 21():79-91. PubMed ID: 3939614
    [Abstract] [Full Text] [Related]

  • 38. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S, Radhakrishnan K.
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Hepatic toxicity of sodium valproate].
    Perignon F, Lenoir G.
    Arch Fr Pediatr; 1982 Apr; 39(4):269. PubMed ID: 6812532
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.